EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia

Background: With the capacity to modulate gene networks in an environmentally-sensitive manner, the role of epigenetic systems in mental disorders has come under intense investigation. Dysregulation of epigenetic effectors, including microRNAs and histone-modifying enzymes, may better explain the ro...

Full description

Bibliographic Details
Main Authors: Andrea L. Johnstone, Jiaqi J. O'Reilly, Annika J. Patel, Zhihong Guo, Nadja S. Andrade, Marco Magistri, Lubov Nathanson, Rustam Esanov, Brooke H. Miller, Gustavo Turecki, Shaun P. Brothers, Zane Zeier, Claes Wahlestedt
Format: Article
Language:English
Published: Elsevier 2018-11-01
Series:Neurobiology of Disease
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S0969996118304194
id doaj-06de208a240d4bfebe4f66a49f8fd752
record_format Article
collection DOAJ
language English
format Article
sources DOAJ
author Andrea L. Johnstone
Jiaqi J. O'Reilly
Annika J. Patel
Zhihong Guo
Nadja S. Andrade
Marco Magistri
Lubov Nathanson
Rustam Esanov
Brooke H. Miller
Gustavo Turecki
Shaun P. Brothers
Zane Zeier
Claes Wahlestedt
spellingShingle Andrea L. Johnstone
Jiaqi J. O'Reilly
Annika J. Patel
Zhihong Guo
Nadja S. Andrade
Marco Magistri
Lubov Nathanson
Rustam Esanov
Brooke H. Miller
Gustavo Turecki
Shaun P. Brothers
Zane Zeier
Claes Wahlestedt
EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
Neurobiology of Disease
miR-132, EZH1, microRNA
Epigenetics
Schizophrenia
Prefrontal cortex
Antipsychotics
author_facet Andrea L. Johnstone
Jiaqi J. O'Reilly
Annika J. Patel
Zhihong Guo
Nadja S. Andrade
Marco Magistri
Lubov Nathanson
Rustam Esanov
Brooke H. Miller
Gustavo Turecki
Shaun P. Brothers
Zane Zeier
Claes Wahlestedt
author_sort Andrea L. Johnstone
title EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
title_short EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
title_full EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
title_fullStr EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
title_full_unstemmed EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
title_sort ezh1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophrenia
publisher Elsevier
series Neurobiology of Disease
issn 1095-953X
publishDate 2018-11-01
description Background: With the capacity to modulate gene networks in an environmentally-sensitive manner, the role of epigenetic systems in mental disorders has come under intense investigation. Dysregulation of epigenetic effectors, including microRNAs and histone-modifying enzymes, may better explain the role of environmental risk factors and the observed heritability rate that cannot be fully attributed to known genetic risk alleles. Here, we aimed to identify novel epigenetic targets of the schizophrenia-associated microRNA 132 (miR-132). Methods: Histone modifications were quantified by immunodetection in response to viral-mediated overexpression of miR-132 while a luminescent reporter system was used to validate targets of miR-132 in vitro. Genome-wide profiling, quantitative PCR and NanoSting were used to quantify gene expression in post-mortem human brains, neuronal cultures and prefrontal cortex (PFC) of mice chronically exposed to antipsychotics. Following viral-mediated depletion of Enhancer of Zeste 1 (EZH1) in the murine PFC, behaviors including sociability and motivation were assessed using a 3-chambered apparatus and forced-swim test, respectively. Results: Overexpression of miR-132 decreased global histone 3 lysine 27 tri-methylation (H3K27me3), a repressive epigenetic mark. Moreover, the polycomb-associated H3K27 methyltransferase, EZH1, is regulated by miR-132 and upregulated in the PFC of schizophrenics. Unlike its homolog EZH2, expression of EZH1 in the murine PFC decreased following chronic exposure to antipsychotics. Viral-mediated depletion of EZH1 in the mouse PFC attenuated sociability, enhanced motivational behaviors, and affected gene expression pathways related to neurotransmission and behavioral phenotypes. Conclusions: EZH1 is dysregulated in schizophrenia, sensitive to antipsychotic medications, and a brain-enriched miR-132 target that controls neurobehavioral phenotypes.
topic miR-132, EZH1, microRNA
Epigenetics
Schizophrenia
Prefrontal cortex
Antipsychotics
url http://www.sciencedirect.com/science/article/pii/S0969996118304194
work_keys_str_mv AT andrealjohnstone ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT jiaqijoreilly ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT annikajpatel ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT zhihongguo ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT nadjasandrade ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT marcomagistri ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT lubovnathanson ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT rustamesanov ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT brookehmiller ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT gustavoturecki ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT shaunpbrothers ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT zanezeier ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
AT claeswahlestedt ezh1isanantipsychoticsensitiveepigeneticmodulatorofsocialandmotivationalbehaviorthatisdysregulatedinschizophrenia
_version_ 1724207863661854720
spelling doaj-06de208a240d4bfebe4f66a49f8fd7522021-03-22T12:47:09ZengElsevierNeurobiology of Disease1095-953X2018-11-01119149158EZH1 is an antipsychotic-sensitive epigenetic modulator of social and motivational behavior that is dysregulated in schizophreniaAndrea L. Johnstone0Jiaqi J. O'Reilly1Annika J. Patel2Zhihong Guo3Nadja S. Andrade4Marco Magistri5Lubov Nathanson6Rustam Esanov7Brooke H. Miller8Gustavo Turecki9Shaun P. Brothers10Zane Zeier11Claes Wahlestedt12The Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA; EpiCypher, Durham, NC, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA; Institute for Biomedical Sciences, George Washington University, Washington, DC, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Pathology, Johns Hopkins University School of Medicine, Baltimore, MD, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAInstitute for Neuro Immune Medicine, Nova Southeastern University, Fort Lauderdale, FL, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA; Department of Neuroscience, The Scripps Research Institute, La Jolla, CA, USAMcKnight Brain Institute and Department of Psychiatry, University of Florida College of Medicine, Gainesville, FL, USADepartment of Psychiatry, McGill University, Quebec, CanadaThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USAThe Center for Therapeutic Innovation and Department of Psychiatry & Behavioral Sciences, University of Miami Miller School of Medicine, Miami, FL, USA; Corresponding author at: Center for Therapeutic Innovation, Department of Psychiatry and Behavioral Sciences, University of Miami Miller School of Medicine, 1501 NW 10th Ave * BRB # 407 (M-860), Miami, FL 33136, USA.Background: With the capacity to modulate gene networks in an environmentally-sensitive manner, the role of epigenetic systems in mental disorders has come under intense investigation. Dysregulation of epigenetic effectors, including microRNAs and histone-modifying enzymes, may better explain the role of environmental risk factors and the observed heritability rate that cannot be fully attributed to known genetic risk alleles. Here, we aimed to identify novel epigenetic targets of the schizophrenia-associated microRNA 132 (miR-132). Methods: Histone modifications were quantified by immunodetection in response to viral-mediated overexpression of miR-132 while a luminescent reporter system was used to validate targets of miR-132 in vitro. Genome-wide profiling, quantitative PCR and NanoSting were used to quantify gene expression in post-mortem human brains, neuronal cultures and prefrontal cortex (PFC) of mice chronically exposed to antipsychotics. Following viral-mediated depletion of Enhancer of Zeste 1 (EZH1) in the murine PFC, behaviors including sociability and motivation were assessed using a 3-chambered apparatus and forced-swim test, respectively. Results: Overexpression of miR-132 decreased global histone 3 lysine 27 tri-methylation (H3K27me3), a repressive epigenetic mark. Moreover, the polycomb-associated H3K27 methyltransferase, EZH1, is regulated by miR-132 and upregulated in the PFC of schizophrenics. Unlike its homolog EZH2, expression of EZH1 in the murine PFC decreased following chronic exposure to antipsychotics. Viral-mediated depletion of EZH1 in the mouse PFC attenuated sociability, enhanced motivational behaviors, and affected gene expression pathways related to neurotransmission and behavioral phenotypes. Conclusions: EZH1 is dysregulated in schizophrenia, sensitive to antipsychotic medications, and a brain-enriched miR-132 target that controls neurobehavioral phenotypes.http://www.sciencedirect.com/science/article/pii/S0969996118304194miR-132, EZH1, microRNAEpigeneticsSchizophreniaPrefrontal cortexAntipsychotics